Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,629.70
-77.00 (-4.51%)
Aug 1, 2025, 3:30 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 3.91 trillion as of August 1, 2025. Its market cap has increased by 3.19% in one year.
Market Cap
3.91T
Enterprise Value
3.68T
Revenue
537.77B
Ranking
n/a
PE Ratio
37.68
Stock Price
1,629.70
Market Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 3.91T, an increase of 14,061.89%. That is a compound annual growth rate of 22.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 3,910.20B | -13.61% |
Dec 31, 2024 | 4,525.99B | 49.78% |
Dec 29, 2023 | 3,021.84B | 25.77% |
Dec 30, 2022 | 2,402.69B | 18.41% |
Dec 31, 2021 | 2,029.07B | 42.77% |
Dec 31, 2020 | 1,421.25B | 36.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Divi's Laboratories | 1,750.90B |
Cipla | 1,255.73B |
Apollo Hospitals Enterprise | 1,078.10B |
Mankind Pharma | 1,059.56B |
Zydus Lifesciences | 975.85B |
Fortis Healthcare | 647.34B |
Aurobindo Pharma | 627.15B |
Glenmark Pharmaceuticals | 602.24B |